Daito Pharmaceutical Cash Flow Statement

Financials in millions JPY. Fiscal year is June - May.

Millions JPY. Fiscal year is Jun - May.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '25 Nov 30, 2025	May '25 May 31, 2025	May '24 May 31, 2024	May '23 May 31, 2023	May '22 May 31, 2022	May '21 May 31, 2021
Net Income	2,913	2,958	4,218	5,076	6,720	5,873
Depreciation & Amortization	4,359	4,332	3,659	3,870	3,313	3,154
Loss (Gain) From Sale of Assets	416	384	165	17	56	315
Loss (Gain) From Sale of Investments	-102	-409	-326	87	-47	-1
Loss (Gain) on Equity Investments	47	-75	-	-	-	-
Other Operating Activities	-320	-571	-1,111	-2,405	-1,820	-1,955
Change in Accounts Receivable	-343	-4,891	2,221	-1,502	-3,299	2,723
Change in Inventory	3,152	2,419	-2,640	-1,413	-1,041	-3,609
Change in Accounts Payable	-1,078	-360	802	538	22	-765
Change in Other Net Operating Assets	355	2,110	-1,806	-113	466	-553
Operating Cash Flow	9,399	5,897	5,182	4,155	4,370	5,182
Operating Cash Flow Growth	85.17%	13.80%	24.72%	-4.92%	-15.67%	20.34%
Capital Expenditures	-3,989	-6,789	-6,220	-5,505	-4,627	-6,318
Sale of Property, Plant & Equipment	-96	-65	-	-	-	-
Cash Acquisitions	-	-707	-	-	-	-
Sale (Purchase) of Intangibles	-616	-241	-56	-51	-106	-31
Investment in Securities	163	438	335	-	256	5
Other Investing Activities	130	-1	11	-10	77	20
Investing Cash Flow	-4,408	-7,365	-5,930	-5,566	-4,400	-6,324
Long-Term Debt Issued	-	6,000	4,000	3,000	1,500	2,000
Total Debt Issued	-	6,000	4,000	3,000	1,500	2,000
Long-Term Debt Repaid	-	-3,099	-2,029	-1,638	-1,444	-1,713
Total Debt Repaid	-3,299	-3,099	-2,029	-1,638	-1,444	-1,713
Net Debt Issued (Repaid)	-3,299	2,901	1,971	1,362	56	287
Issuance of Common Stock	-	-	-	302	1,527	1,798
Repurchase of Common Stock	-1,227	-623	-1,176	-110	-	-
Common Dividends Paid	-1,061	-998	-907	-931	-660	-658
Other Financing Activities	-374	-278	-71	-7	66	-3
Financing Cash Flow	-5,961	1,002	-183	616	989	1,424
Foreign Exchange Rate Adjustments	-48	-54	51	20	48	5
Miscellaneous Cash Flow Adjustments	1	1	1	1	1	1
Net Cash Flow	-1,017	-519	-879	-774	1,008	288
Free Cash Flow	5,410	-892	-1,038	-1,350	-257	-1,136
Free Cash Flow Margin	10.57%	-1.76%	-2.21%	-2.99%	-0.59%	-2.33%
Free Cash Flow Per Share	180.05	-29.32	-33.08	-42.65	-8.39	-37.82
Cash Interest Paid	134	126	40	13	9	7
Cash Income Tax Paid	614	842	1,265	2,411	1,924	2,088
Levered Free Cash Flow	3,394	-4,444	330.13	-918	-406.63	-2,781
Unlevered Free Cash Flow	3,478	-4,367	355.75	-910.5	-401	-2,776
Change in Working Capital	2,086	-722	-1,423	-2,490	-3,852	-2,204

Updated Nov 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.